The expression of EPCAM increases the expression of stemness markers (NANOG, SOX2, and OCT4) in cancer cells [19,20], and EPCAM has been described as a marker of cancer stem cells in colorectal, prostate, pancreatic, and breast cancers [21,22,23,24,25,26]. This evidence concerns the gene EPCAM and breast carcinoma.